Literature DB >> 9176090

Micrometastases: are they clinically significant disease?

H J Andreyev1, D Cunningham.   

Abstract

Mesh：

Year:  1997        PMID： 9176090      PMCID： PMC1027136          DOI： 10.1136/gut.40.4.555

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Prognostic significance of bone marrow micrometastases in patients with gastric cancer.

Authors:  K W Jauch; M M Heiss; U Gruetzner; I Funke; K Pantel; R Babic; H J Eissner; G Riethmueller; F W Schildberg
Journal:  J Clin Oncol       Date:  1996-06       Impact factor: 44.544

2.  Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up.

Authors:  J L Mansi; D Easton; U Berger; J C Gazet; H T Ford; D Dearnaley; R C Coombes
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

3.  Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction.

Authors:  S T Traweek; J Liu; H Battifora
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

Review 4.  Adjuvant chemotherapy for colorectal cancer.

Authors:  D J Kerr; R Gray
Journal:  Br J Hosp Med       Date:  1996 Mar 6-19

5.  Microsatellite alterations in plasma DNA of small cell lung cancer patients.

Authors:  X Q Chen; M Stroun; J L Magnenat; L P Nicod; A M Kurt; J Lyautey; C Lederrey; P Anker
Journal:  Nat Med       Date:  1996-09       Impact factor: 53.440

6.  Adjuvant therapy for stage III colon cancer: economics returns to research and cost-effectiveness of treatment.

Authors:  M L Brown; S G Nayfield; L M Shibley
Journal:  J Natl Cancer Inst       Date:  1994-03-16       Impact factor: 13.506

7.  Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.

Authors:  R J Cote; P P Rosen; M L Lesser; L J Old; M P Osborne
Journal:  J Clin Oncol       Date:  1991-10       Impact factor: 44.544

Review 8.  Cost and quality of life: thrombolysis and primary angioplasty.

Authors:  L Goldman
Journal:  J Am Coll Cardiol       Date:  1995-06       Impact factor: 24.094
  8 in total
  1 in total

1.  The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients.

Authors:  G de Manzoni; G Pelosi; F Pavanel; A Di Leo; C Pedrazzani; E Durante; C Cordiano; F Pasini
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.